About the Company
We do not have any company description for CollPlant Biotechnologies Ltd at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call Transcript
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) Q3 2023 Earnings Conference Call November 29, 2023 10:00 AM ET Company Participants Dory Kurowski - Investor Relations Yehiel Tal - Chief Executive ...
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call ...
With us on the call today from CollPlant Biotechnologies Ltd., are Yehiel Tal, Chief Executive Officer, who will provide a brief overview of the company’s programs and associated updates, and ...
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Stock's Been Sliding But ...
CollPlant Biotechnologies (NASDAQ:CLGN) has had a rough three months with its share price down 36%. But if you pay close attention, you might find that its key financial indicators look quite ...
CollPlant Biotechnologies Ltd Ordinary Shares New CLGN - Morningstar
Check out our CLGN stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.
Earnings Preview: CollPlant Biotechnologies
Market Performance of CollPlant Biotechnologies's Stock Shares of CollPlant Biotechnologies were trading at $1.93 as of May 26. Over the last 52-week period, shares are down 65.85%.
Why CollPlant Biotechnologies Stock Is Trading Higher
CollPlant Biotechnologies Ltd (NASDAQ: CLGN) shares are trading higher Monday after the company announced it achieved a milestone in its product collaboration agreement with AbbVie Inc (NYSE: ...
Is CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shareholder Ownership ...
The big shareholder groups in CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see ...
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q1 2024 Earnings Call ...
CollPlant Biotechnologies Ltd. misses on earnings expectations. Reported EPS is $-0.36627 EPS, expectations were $-0.35. Operator: Welcome to the CollPlant Biotechnology Investor Conference Call ...
CollPlant Biotechnologies Ltd - Ordinary Shares New
CollPlant Biotechnologies Ltd - Ordinary Shares New Competitors - Telecommunications Equipment Abbott Laboratories ABT Company$128.22 Price USD15.14%15.14% Returns 1-YEAR9.57%9.57% RETURNS 5-year ...
Similar Companies
Loading the latest forecasts...